Dr. Michael Pollak to co-lead Metastatic Breast Cancer Dream Team
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
JGH leads Canada in performing advanced robotic surgery for gynecologic cancer
The JGH has become the first hospital in Canada to perform an advanced type of robotic surgery for gynecologic cancer, in which all of the medical instruments are inserted into the abdomen via a single, tiny incision in the navel.
Promising therapy for relapsed patients with aggressive form of lymphoma
A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.
Segal Cancer Centre joins the “Cancer Moonshot”
The Segal Cancer Centre is taking “one small step” that could lead to “one giant leap” in a metaphorical moonshot to conquer cancer.
Key mechanism identified in deadly brain tumours
A key to understanding the formation of the most aggressive type of brain tumour in adults has been revealed at the JGH.
JGH praised for attention to needs of young adults with cancer
The Segal Cancer Centre at the JGH has distinguished itself as the only medical centre in Quebec to serve the needs of adolescents and young adults with cancer by providing a dedicated clinic staffed by a multi-disciplinary team.
Partnership supports cancer-fighting
power of protein analysis
Dr. Christoph Borchers has established the first pan-Canadian proteomics program, custom-tailoring cancer treatments to meet the needs of individual patients